Biblio
Journal Article
Bouabdallah K, Fürst S, Asselineau J, Chevalier P, Tournilhac O, Ceballos P, Vigouroux S, Tabrizi R, Doussau A, Bouabdallah R, et al. 90Y-ibritumomab tiuxetan, fludarabine, busulfan and anti-thymocyte globulin reduced intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas. Ann Oncol. 2014.